Recent Analyst Forecasts and Stock Ratings
Monopar Therapeutics Inc. FAQ's
Monopar Therapeutics Inc. has been rated by research analysts at Morgan Stanley, Raymond James, Barclays, Oppenheimer, H.C. Wainwright, Chardan Capital in the past 90 days.
Monopar Therapeutics Inc. has been rated by research analysts at Morgan Stanley, Raymond James, Barclays, Oppenheimer, H.C. Wainwright, Chardan Capital in the past 90 days.